Antimicrobial Agents and Chemotherapy · 2013 · 51 citations · 17 references
Life SciencesInfectious DiseasesMicrobiologyAntimicrobial PharmacotherapyAntimicrobial ResistanceMedical MicrobiologyAntibacterial ResistanceAntibiotic ResistanceAntibiotic Resistance MechanismsBiofilm-associated ResistanceCombination Antimicrobial TherapyMultidrug ResistanceAntimicrobial Resistance In BiofilmsBeta-lactam Resistance In BiofilmsBiofilm DynamicsBiofilm GrowthBiofilm-associated Antimicrobial ResistanceBiofilm-associated InfectionsMethicillin-resistant Staphylococcus Aureus TreatmentResistance Mechanisms In Staphylococci
To compare the in vitro antibacterial efficacies and resistance profiles of rifampin-based combinations against methicillin-resistant Staphylococcus aureus (MRSA) in a biofilm model, the antibacterial activities of vancomycin, teicoplanin, daptomycin, minocycline, linezolid, fusidic acid, fosfomycin, and tigecycline alone or in combination with rifampin against biofilm-embedded MRSA were measured. The rifampin-resistant mutation frequencies were evaluated. Of the rifampin-based combinations, rifampin enhances the antibacterial activities of and even synergizes with fusidic acid, tigecycline, and, to a lesser extent, linezolid, fosfomycin, and minocycline against biofilm-embedded MRSA. Such combinations with weaker rifampin resistance induction activities may provide a therapeutic advantage in MRSA biofilm-related infections.
17
Catherine Liu, Arnold S. Bayer, Sara E. Cosgrove et al. · Clinical Infectious Diseases · 2011 · 4.2K citations · Full text
Infectious Diseases Society of America
J. F. Enders · The Journal of Infectious Diseases · 1969 · 3.3K citations
Benjamin P. Howden, Peter Ward, Patrick G. P. Charles et al. · Clinical Infectious Diseases · 2004 · 485 citations
Issam Raad, Hend Hanna, Ying Jiang et al. · Antimicrobial Agents and Chemotherapy · 2007 · 346 citations · Full text